New Delhi, India

Venkatasamy Manivel


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkatasamy Manivel: Innovator in Osteoporosis Treatment

Introduction

Venkatasamy Manivel is a notable inventor based in New Delhi, India. He has made significant contributions to the field of medical science, particularly in the treatment of osteoporosis. His innovative approach has led to the development of a unique method and composition that addresses this prevalent condition.

Latest Patents

Venkatasamy Manivel holds a patent for a method and composition for treating osteoporosis. This invention relates to a novel class of acidic amino acid/dicarboxylic acid derivatives, specifically sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides. These compounds serve as inhibitors of osteoclastogenesis, which is crucial in the management of osteoporosis. The invention provides methods for utilizing these derivatives, represented by the general formula ZOC—(CRR)—COOH, where m can be 2, 3, or 4. The components of this formula include Z as OH or NH, with one R being from a specific group and the remaining Rs being H or NH.

Career Highlights

Venkatasamy Manivel is affiliated with the Council of Scientific & Industrial Research, where he continues to engage in groundbreaking research. His work has not only advanced scientific understanding but also holds the potential for practical applications in treating osteoporosis.

Collaborations

He has collaborated with esteemed colleagues such as Kanury Venkata Subba Rao and Mohan Ramachandran Wani, contributing to a rich environment of innovation and research.

Conclusion

Venkatasamy Manivel's contributions to the field of osteoporosis treatment exemplify the impact of innovative thinking in medical science. His patent reflects a significant advancement that could improve the quality of life for many individuals affected by this condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…